1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStefanache, Camelia Paula-
dc.contributor.authorImseng, Nicole-
dc.contributor.authorMeier, Beat-
dc.contributor.authorTanase, Catalin-
dc.contributor.authorEibl-Schindler, Regine-
dc.contributor.authorPeter, Samuel-
dc.contributor.authorWolfram, Evelyn-
dc.date.accessioned2018-01-17T10:45:38Z-
dc.date.available2018-01-17T10:45:38Z-
dc.date.issued2013-
dc.identifier.issn0032-0943de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/2084-
dc.description.abstractArnica montana L. is a medicinal plant with traditional use to treat sprains, bruises, rheumatic and muscular aches based on the anti-inflammatory properties of sesquiterpene lactones (SL), mainly esters of helenalin and dihydrohelenalin. Overexploitation has led to conservation actions in the majority of European countries, involving in vitro cultivation techniques as a sustainable alternative. Cell suspension cultures of A. montana have not been reported extensively, although a sustainable biotechnological process in bioreactors for production of the active plant secondary metabolites is of great interest for industry. The starting plant material consisted of seeds, collected from wild populations in the Romanian Eastern Carpathians. Germination in aseptic environment lead to sterile plantlets for the micropropagation process. Leaf fragments of about 1 cm2 were placed on several medium variants – MS medium supplemented with different amount of 2,4-dichlorophenoxyacetic acid and benzylaminopurine for callus induction. First qualitative results show that suspension cultures from the obtained calli in small scale single-use bioreactors have been successfully established. Due to small biomass amounts, common HPLC and HPTLC methods from the Ph Eur Monograph on Arnica for SL, flavonoids and phenolic acids using HPLC and HPTLC had to be optimized to very low sample amounts. Quantitative assessment of the desired secondary metabolites is under way in parallel to the continuous culturing process. The final aim of the study is to show differences in secondary metabolite content in plant material from the field, callus and cell suspensions.de_CH
dc.language.isoende_CH
dc.publisherThiemede_CH
dc.relation.ispartofPlanta Medicade_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc660.6: Biotechnologiede_CH
dc.titleArnica montana L. cell suspension culture as a biotechnological approach for the production of bioactive secondary metabolitesde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1055/s-0033-1352447de_CH
zhaw.funding.euNode_CH
zhaw.issue13de_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume79de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Stefanache, C. P., Imseng, N., Meier, B., Tanase, C., Eibl-Schindler, R., Peter, S., & Wolfram, E. (2013). Arnica montana L. cell suspension culture as a biotechnological approach for the production of bioactive secondary metabolites. Planta Medica, 79(13). https://doi.org/10.1055/s-0033-1352447
Stefanache, C.P. et al. (2013) ‘Arnica montana L. cell suspension culture as a biotechnological approach for the production of bioactive secondary metabolites’, Planta Medica, 79(13). Available at: https://doi.org/10.1055/s-0033-1352447.
C. P. Stefanache et al., “Arnica montana L. cell suspension culture as a biotechnological approach for the production of bioactive secondary metabolites,” Planta Medica, vol. 79, no. 13, 2013, doi: 10.1055/s-0033-1352447.
STEFANACHE, Camelia Paula, Nicole IMSENG, Beat MEIER, Catalin TANASE, Regine EIBL-SCHINDLER, Samuel PETER und Evelyn WOLFRAM, 2013. Arnica montana L. cell suspension culture as a biotechnological approach for the production of bioactive secondary metabolites. Planta Medica. 2013. Bd. 79, Nr. 13. DOI 10.1055/s-0033-1352447
Stefanache, Camelia Paula, Nicole Imseng, Beat Meier, Catalin Tanase, Regine Eibl-Schindler, Samuel Peter, and Evelyn Wolfram. 2013. “Arnica Montana L. Cell Suspension Culture as a Biotechnological Approach for the Production of Bioactive Secondary Metabolites.” Planta Medica 79 (13). https://doi.org/10.1055/s-0033-1352447.
Stefanache, Camelia Paula, et al. “Arnica Montana L. Cell Suspension Culture as a Biotechnological Approach for the Production of Bioactive Secondary Metabolites.” Planta Medica, vol. 79, no. 13, 2013, https://doi.org/10.1055/s-0033-1352447.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.